PM Modi Speaks with Biden on the Phone and Discussed over COVID-19 situation and supply of COVID-19 vaccine raw materials

PM-Modi-speaks-with-Biden-on-the-Phone-over-COVID-19
The President pledged PM Modi the continued support of the US for the people of India affected by the recent upsurge in COVID-19 cases

Prime Minister Narendra Modi spoke to US President Joe Biden on Monday and discussed the importance of a smooth and efficient supply chain of COVID-19 vaccine raw materials in a telephone conversation.

Narendra Modi tweeted

US President Joe Biden tweeted

Also, read | Covid-19: Why Center Advises to Wear Masks Even at Home

Important points from Modi, Biden discussion on COVID-19 situation

  • President Biden conveyed solidarity with India and affirmed that the United States was determined to support India’s India’s efforts by quickly deploying resources such as therapeutics, ventilators, and identifying sources of raw materials to be made available for the manufacture of Covishield vaccines.
  • White House Announces Oxygen Supply, Raw Materials for COVID-19 Vaccines, from Important Life-Saving Drugs to PPEs.
  • PM Modi conveyed his heartfelt appreciation for the offer of assistance and support from the American government. He mentioned India’s commitment to contain the Covid-19 pandemic globally through Vaccine Maitri, and its participation in COVAX and the Quad Vaccine Initiatives.
  • India was there for us, and we will be there for them,” Joe Biden said in a tweet soon after his phone call with PM Modi.
  • The two leaders are believed to have held talks for about 45 minutes. During the call, Biden is understood that India should offer all help in this hour of crisis.

After speaking with Union Minister S Jaishankar and NSA Ajit Blinken and US NSA Jake Sullivan, the US administration decided to take steps to help India. Following Doval’s negotiations with Sullivan, a US National Security Council spokesman issued a statement saying the US was identifying the resources needed by India as it fights the second wave.

White House Press Secretary Jen Psaki told reporters at the daily news conference over PM Modi and Biden discussion

  • The President pledged the continued support of the US for the people of India affected by the recent upsurge in COVID-19 cases.
  • At the request of India, the United States is exploring options to provide oxygen and related supplies. The Department of Defense and USAID are pursuing options to provide oxygen production systems.
  • Given the urgency of the circumstances in India, we may be in a position to remodel a plan of shipment to countries with less immediate needs, and we will soon give more information on the possibility.
  • The Department of Defense, she said, is providing the area oxygen production system that the United States has used in its medical hospitals.
  • Each unit can provide oxygen for 50 to 100 beds. The administration is also exploring options for providing oxygen concentrations and ventilators and has technical discussions with India to ensure that American supplies can connect to Indian equipment.
  • India has submitted a list of seven essential items that it needs on an urgent basis. These are oxygen concentrators, oxygen cylinders with 10 liters and 45-liter capacity, oxygen generators, oxygen generation plants, remdesivir, favipiravir, and tocilizumab.
  • We will provide raw materials for the production of the AstraZeneca Covishield vaccine at Serum Institute of India
  • Psaki said the US has identified rapid diagnostic testing supplies, personal protective equipment, and additional ventilators available to be transferred to India immediately.
  • India and the United States stated that the two biggest challenges are because it relates to fighting the COVID epidemic, so we keep that in mind. But I can assure those who are watching and noting that we want to work in partnership with India.

For daily news updates related to finance, business and sports keep following our portal Daily News Capsule

 

 

Leave a Reply

Your email address will not be published. Required fields are marked *